期刊文献+

鼻咽癌放疗近期疗效的多因素分析 被引量:3

Multi-factor analysis of primary efficacy of nasopharyngeal carcinoma patients treated with radiotherapy
下载PDF
导出
摘要 目的:分析鼻咽癌放疗近期疗效的相关因素。方法:分析76例经病理证实的接受根治性放疗的鼻咽癌初治患者资料,分析其年龄、性别、原发肿瘤体积、放疗结束时残留肿瘤体积、原发肿瘤最大截面积、T分期、N分期、病理类型等因素与放疗50Gy时肿瘤退缩率(V50/V0、S50/S0)的关系。通过对原发肿瘤体积(V0)、50Gy肿瘤退缩率(V50/V0)、放疗结束时残留肿瘤体积(V70)进行均数统计分析,并对以上因素和放疗50Gy残留肿瘤体积(V50)进行多因素相关分析。结果:随T分期渐晚,肿瘤原发体积增大,T4期肿瘤退缩未达PR。肿瘤病理类型中未分化癌原发肿瘤体积最大,腺样囊性癌体积最小,但V50/V0中高分化鳞癌、腺样囊性癌未达PR,分别为(0.68、0.55),显示肿瘤病理类型与近期疗效密切相关(P=0.000),V50/V0(体积退缩率)与S50/S0(最大截面积退缩率)在反映肿瘤近期疗效时,密切相关,有很好的一致性。结论:50Gy时肿瘤退缩率是评价近期疗效的较可靠指标,可部分反映肿瘤放射敏感性。肿瘤最大体积退缩率与肿瘤最大截面积退缩率均可作为评价近期疗效的指标。 Objective :To analyze influential factors of nasopharyngeal carcinoma (NPC) patients treated with radiotherapy. Methods: The information of 76 NPC patients proved by pathology who received radiotherapy were analyzed retrospectively and the relationship between the regression rate of tumor delivered 50 GY ( V50/V0, S50/S0) and age, sex, primary tumor volume, remain tumor volume of radiation treatment,cross section, T stage, N stage, histological type were analyzed. Results: T stage, the bigger of primary tumor volume and T4 stage patients didn't get PR, the tumor volume in undifferentiated carcinoma was biggest but smallest in adenoid cystic carcinoma, in well - differentiated carcinoma and adenoid cystic carcinoma V50/V0 were 0.68,0.55 respectively, tumor histological type was significantly associated with primary efficacy (P = 0. 000). V50/V0 and S50/S0 were significantly related to primary efficacy. Conclusion : The regression rate of tumor delivered 50 GY is a good index in primary efficacy evaluation and can partly reflect sensitivity of tumor radiotherapy. Volume and section regression rate of tumor can both be indexes to evaluate tumor primary efficacy.
出处 《现代肿瘤医学》 CAS 2006年第11期1362-1364,共3页 Journal of Modern Oncology
关键词 鼻咽肿瘤 放射疗法 体层摄影术 影响因素 nasopharyneal carcinoma radiotherapy tomography influential factor
  • 相关文献

参考文献5

  • 1Chang CC,Cheu MK,Liu MT,et al.The effect of primary tumor volumes in advanced T-staged nasopharyngeal tumors[J].Head Neck,2002,24:940 ~ 946.
  • 2Willner J,Baier K,Pfreundner L,et al.Tumor volume and local control in primary radiotherapy of nasopharyngeal carcinoma[J].Acta Oncol,1999,38:1025 ~ 1029.
  • 3Fang FM,Tsai WL,Go SF,et al.Implications of quantitative tumor and nodal regression rates for nasopharyngeal carcinomas after 45 Gy of radiotherapy[J].Int J Radiat Oncol Biol Phys,2001,50:961~969.
  • 4肖建平,徐国镇,高黎,秦德兴,蔡伟民,李素艳.鼻咽癌初程放疗后残存的分次X刀治疗初探[J].中华放射肿瘤学杂志,2005,14(2):77-80. 被引量:24
  • 5易俊林,高黎,黄晓东,李素艳,罗京伟,徐国镇.鼻咽癌放射治疗的失败模式[J].中华放射肿瘤学杂志,2004,13(3):145-148. 被引量:89

二级参考文献13

  • 1崔书祥,王迎选,赵路军,孙洪森,陈国雄.203例鼻咽癌的预后与死亡因素分析[J].军医进修学院学报,1995,16(3):178-180. 被引量:1
  • 2Qin DX, Hu YH, Yan JH. Analysis of 1379 patiens with nasopharyngeal carcinoma treated by radiation. Cancer,1988,61:1117-1124.
  • 3Yan JH, Xu GZ, Hu YH. Management of local residual primary lesion of nasopharyngeal carcinoma : Ⅱ. results of prospective randomized trial on booster dose. Int J Radiat Onncol Biol Phys,1990,18:295-298.
  • 4严洁华 徐国镇.[A].见:殷蔚伯 谷铣之 主编.肿瘤放射治疗学 第3版[C].北京:中国协和医科大学出版社,2002.537-573.
  • 5Tu GY, Hu YH, XU GZ. Selvage Surgery for Nasopharyngeal Carcinoma. Arch otolaryngol Head Neck Surg, 1988, 114:328.
  • 6Xiao JP, Xu GZ, Miao YJ. Fractionated stereotactic radiosurgery for 50 patients with recurrent or residual nasopharyngery carcinoma. Int J Radiat Oncol Biol Phys,2001,51:164-170.
  • 7Buatti JM. Linac radio radiosugery for locally recurrent nasopharyngeal carcinoma: rationale and technique.Head Neck,1995,17:14-19.
  • 8Kondzioka D, Lunsford LD. Stereotactic radiosurgery for squamous cell carcinoma of the nasopharynx. Laryngoscope,1991,101:519-522.
  • 9Firlik KS, Kondzioka D.Radiosurgery for recurrent cranial base cancer arising from the head and neck. Head Neck,1996,18:160-166.
  • 10洪明晃,方积乾,马骏,闵华庆,张恩罴,张锦明,张峰.应用无复发生存率和无远处转移生存率进行肿瘤预后的评价——附411例鼻咽癌资料分析[J].癌症,1998,17(2):118-120. 被引量:17

共引文献109

同被引文献24

引证文献3

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部